STAIR III

Stroke Treatment Academic Industry Roundtable

April 6-7, 2002 Cambridge, Massachusetts 

"Stroke Drug Development:

Expanding the Scope of Acute Drug Therapy"

Program

Sponsors

Recommendations for Advancing Therapies of Acute Stroke Treatment

Published in the Journal Stroke 2003;34:1539-1606

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group